Stay updated with breaking news from Tomasz Beer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Findings from the phase 3 randomized CABASTY clinical trial “may be practice changing,” investigators reported. Biweekly vs triweekly cabazitaxel for mCRPC in men aged 65 years or older has similar efficacy but is associated with a lower risk for neutropenia and/or neutropenic complications.
The tests screen for cancers that often go undetected, but they are expensive and some experts worry they could lead to unnecessary treatments without saving patients’ lives.
Several drug companies are pushing for the blood test as part of regular health screening to find cancerous growths. Experts are not sure whether the tests could improve Americans’ health or help cut the cancer death rate.
Can cancer blood tests live up to the promise of saving lives?
Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer.